Read more about the article RSNA 2023
Combinostics at RSNA 2023

RSNA 2023

Attending RSNA 2022? Stop by booth 3938 in the AI Showcase to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.

Continue ReadingRSNA 2023

Combinostics new PET quantification application cNeuro cPET receives FDA 510(k) clearance

New cPET application for amyloid and FDG brain PET quantification further extends Combinostics’ solutions across the entire patient pathway for neurological disorders and supports end-to-to-end workflows.

Continue ReadingCombinostics new PET quantification application cNeuro cPET receives FDA 510(k) clearance

Revolutionising Precision Medicine: PROMINENT Project will Enhance Diagnosis and Treatment of Neurodegenerative Diseases, Improving Patients’ Lives Across Europe

Stockholm, 14 June 2023 – Today, partners of the PROMINENT project announced the launch of…

Continue ReadingRevolutionising Precision Medicine: PROMINENT Project will Enhance Diagnosis and Treatment of Neurodegenerative Diseases, Improving Patients’ Lives Across Europe